News
Windlas Biotech consolidated net profit rises 13.67% in the September 2025 quarter
07-Nov-2025 | 07:41
Sales rise 18.93% to Rs 222.40 crore
Net profit of Windlas Biotech rose 13.67% to Rs 17.80 crore in the quarter ended September 2025 as against Rs 15.66 crore during the previous quarter ended September 2024. Sales rose 18.93% to Rs 222.40 crore in the quarter ended September 2025 as against Rs 187.00 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 222.40 | 187.00 | 19 |
| OPM % | 12.84 | 12.33 | - |
| PBDT | 31.19 | 26.79 | 16 |
| PBT | 23.59 | 20.29 | 16 |
| NP | 17.80 | 15.66 | 14 |
Powered by Capital Market - Live News